SENORES PHARMACEUTICALS L Financial Ratios
SENORES · Healthcare · Current price ₹1,448.8
P/E ratio
57.8x
P/B ratio
6.6x
ROE
13.4%
ROCE
15.0%
Debt / Equity
0.11
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 57.8x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 6.6x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 13.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 15.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.11 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with SENORES PHARMACEUTICALS L's latest numbers.
SENORES PHARMACEUTICALS L profitability
SENORES PHARMACEUTICALS L generates a return on equity of 13.4% and a return on capital employed of 15.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.11 and a P/E of 57.8x, SENORES PHARMACEUTICALS L is conservatively financed. Our overall business-quality score for the company is 5.5 / 10.
Understand the ratios
More on SENORES PHARMACEUTICALS L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.